What is Synerkine Pharma?
Synerkine Pharma is a preclinical stage biotechnology firm established in 2018 and headquartered in the Netherlands. The company is dedicated to the development of a new generation of potent cytokine fusion proteins. These therapeutic candidates are designed to address significant unmet medical needs in conditions such as chronic pain, osteoarthritis, and chemotherapy-induced neuropathy. The company's focus on these debilitating diseases positions it within a critical segment of the pharmaceutical market.
How much funding has Synerkine Pharma raised?
Synerkine Pharma has raised a total of $8M across 1 funding round:
Series A
$8M
Series A (2021): $8M with participation from Thuja Capital, Utrecht Holdings, and Flerie Invest
Key Investors in Synerkine Pharma
Thuja Capital
Thuja Capital is a venture capital firm specializing in early-stage life science companies, providing strategic investment and deep sector expertise to drive healthcare innovation.
Utrecht Holdings
Utrecht Holdings supports the commercialization of research from Utrecht University and UMC Utrecht, offering legal, strategic, and financial assistance for developing new therapies and advanced applications.
Flerie Invest
Flerie Invest focuses on venture and growth stage companies involved in drug development, aiming to tackle significant medical challenges with innovative solutions.
What's next for Synerkine Pharma?
The recent major strategic investment provides Synerkine Pharma with substantial resources to advance its pipeline through preclinical development and potentially into clinical trials. This infusion of capital is expected to accelerate research and development efforts, enabling the company to further validate its innovative therapeutic approach. The strategic nature of this financing suggests a strong alignment with investors who believe in the long-term potential of Synerkine Pharma's technology to create transformative treatments for patients suffering from severe and chronic conditions.
See full Synerkine Pharma company page
